30 June 2016
Monica Healthcare is a winner in the 2016 Premier Inc Innovation Celebrations
GE Healthcare on behalf of Monica Healthcare showcased the Monica Novii Wireless Patch System at Premier Inc.’s 2016 annual Breakthroughs Conference. Monica’s Novii System is one of the medical innovations that was showcased in front of thousands of healthcare...
9 June 2016
Catapult Ventures appoints Dr David Whitcombe as Venture Partner
Catapult Ventures has announced that Dr David Whitcombe has become a Venture Partner with its new GM&C Life Sciences Fund. Dr Whitcombe, who has worked alongside Catapult and its portfolio companies for a number of years informally, is best known as a co-founder of DxS...
8 June 2016
Probe Scientific in top disruptive medical technologies index
British early stage medical device and diagnostic company, Probe Scientific Ltd has been named one of the world’s most influential companies on the Disrupt 100 index which lists “companies shaping our futures”. The largest sector for disruption is Health Tech...
26 May 2016
Catapult Ventures sells Haemostatix to Ergomed
Catapult Ventures has completed the sale of its stake in Haemostatix Limited (‘Haemostatix’) to Ergomed plc (‘Ergomed’). Ergomed is acquiring 100 per cent of the issued share capital of Haemostatix for an initial consideration of £8.0 million, with...
26 May 2016
Three weeks: Four trophies: One BWB!
BWB’s commitment to the next generation of engineering talent has secured national recognition from one of the industry’s most influential organisations – and a remarkable awards double! ACE – the Association for Consultancy and Engineering – held...
12 May 2016
Yospace wins at Mediatel’s Connected Consumer Awards
Yospace is delighted to have won in the Connected Content Service of the Year category of Mediatel’s prestigious Connected Consumer Awards. The category recognizes innovations such as new advertising models and formats and was awarded to Yospace for its work with Channel 4...
5 May 2016
Blueberry Therapeutics raises £3m led by GM&C Life Sciences Fund
Alderley Park, Cheshire, UK - 5th May 2016. Blueberry Therapeutics today announced that it has raised £3 million to progress the development of its topical fungal infection therapies into human clinical trials. The investment was led by the GM&C Life Sciences Fund...
28 April 2016
Yospace Wins NewBay Media’s Best of Show Award, Presented by TV Technology
Yospace is delighted to have won NewBay Media’s Best of Show Award, presented at the 2016 NAB Show in Las Vegas by TV Technology. The award recognises the importance of Yospace’s Dynamic Ad Insertion platform in enabling live channels to be monetised when viewed...
13 April 2016
Catapult exits Food and Drug Analytical Services
6 April 2016
Oxford BioTherapeutics Licenses Nerviano Medical Sciences' Drug-Linker Technology to Develop Novel Antibody Drug Conjugates
Oxford BioTherapeutics (OBT), a company developing a range of innovative Antibody Drug Conjugates (ADCs) for the treatment of cancer and Nerviano Medical Sciences (Nerviano), a company of the NMS Group dedicated to the discovery and development of breakthrough treatments for...